Activity Report and Latest Information
- HOME
- Activity Report and Latest Information
- Latest infromation: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Latest infromation: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Reports have been made regarding the registration, reimbursement, and restrictions of direct-acting antiviral drugs (DAAs), which are therapeutic agents for hepatitis C virus infection, in various countries.
